CO [China Cord Blood] F-3: (Original Filing)

[CALCULATION OF REGISTRATION FEE Title of each class of securities to be registered (1) Amount (2) Proposed (1)(3) Proposed Amount of (4) Ordinary shares, par value $0.0001 per share Preferred shares, par value $0.0001 per share] [12 September 2013 Matter No.: Doc Ref: RJH/3780935 Tel No.: 852 2842 9530 E-mail: Richard.Hall@conyersdill.com China Cord Blood Corporation th 48 1 Garden Road, Central Hong Kong S.A.R. Dear Sirs, Re: China Cord Blood Corporation (the “Company”) Registration Statement Commission Securities Act Ordinary Shares Preferred Shares Equity Securities Debt Securities (the “ Rights Units Securities We have acted as special] [345 Park Avenue New York, NY 10154-1895 Direct Main Fax September 12, 2013 China Cord Blood Corporation th 48 Re: Registration Statement on Form F-3 Ladies and Gentlemen: China Cord Blood Corporation September 12, 2013 2 Page China Cord Blood Corporation September 12, 2013 3 Page China Cord Blood Corporation September 12, 2013 4 Page The opinions set forth above] [. Year Ended March 31, 2013 2012 2011 2010 2009 Ratio of earnings to fixed charges 3.2 27.6 30.6 19.2 30.1 Earnings: Year Ended March 31, RMB’000 2013 2012 2011 2010 2009 Income before income tax 158,185 151,599 132,142 79,663 42,299 Add: Fixed charges Interest expense 70,097] [Consent of Independent Registered Public Accounting Firm The Board of Directors China Cord Blood Corporation We consent to the use of our reports dated July 31, 2013, with respect to the consolidated balance sheets of China Cord Blood Corporation and subsidiaries as of March 31, 2012 and 2013, and the related consolidated statements of comprehensive income, changes in equity, and] [China Cord Blood Corporation 48th Floor , Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Madams and Sirs , We hereby consent to the use of our name under the captions "Enforceability of Civil Liabilities ", " Legal Matters " and " Experts " in the registration statement on Form F-3 (the " Registration Statement " r]

By | 2016-02-29T13:16:09+00:00 September 12th, 2013|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] F-3: CALCULATION OF REGISTRATION FEE Title of each class

[CALCULATION OF REGISTRATION FEE Title of each class of securities to be registered (1) Amount (2) Proposed (1)(3) Proposed Amount of (4) Ordinary shares, par value $0.0001 per share Preferred shares, par value $0.0001 per share] [12 September 2013 Matter No.: Doc Ref: RJH/3780935 Tel No.: 852 2842 9530 E-mail: Richard.Hall@conyersdill.com China Cord Blood Corporation th 48 1 Garden Road, Central Hong Kong S.A.R. Dear Sirs, Re: China Cord Blood Corporation (the “Company”) Registration Statement Commission Securities Act Ordinary Shares Preferred Shares Equity Securities Debt Securities (the “ Rights Units Securities We have acted as special] [345 Park Avenue New York, NY 10154-1895 Direct Main Fax September 12, 2013 China Cord Blood Corporation th 48 Re: Registration Statement on Form F-3 Ladies and Gentlemen: China Cord Blood Corporation September 12, 2013 2 Page China Cord Blood Corporation September 12, 2013 3 Page China Cord Blood Corporation September 12, 2013 4 Page The opinions set forth above] [. Year Ended March 31, 2013 2012 2011 2010 2009 Ratio of earnings to fixed charges 3.2 27.6 30.6 19.2 30.1 Earnings: Year Ended March 31, RMB’000 2013 2012 2011 2010 2009 Income before income tax 158,185 151,599 132,142 79,663 42,299 Add: Fixed charges Interest expense 70,097] [Consent of Independent Registered Public Accounting Firm The Board of Directors China Cord Blood Corporation We consent to the use of our reports dated July 31, 2013, with respect to the consolidated balance sheets of China Cord Blood Corporation and subsidiaries as of March 31, 2012 and 2013, and the related consolidated statements of comprehensive income, changes in equity, and] [China Cord Blood Corporation 48th Floor , Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Madams and Sirs , We hereby consent to the use of our name under the captions "Enforceability of Civil Liabilities ", " Legal Matters " and " Experts " in the registration statement on Form F-3 (the " Registration Statement " r]

By | 2016-02-29T13:16:44+00:00 September 12th, 2013|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

DQ [DAQO NEW ENERGY] 6-K: (Original Filing)

[Daqo New Energy Announces Unaudited Second Quarter 2013 Results CHONGQING, China—September 11, 2013—Daqo New Energy Corp. (NYSE: DQ) (“Daqo New Energy” or the “Company”), a leading polysilicon manufacturer based in China, today announced its unaudited financial results for the second quarter of 2013. Second Quarter 2013 Financial and Operating Highlights • Polysilicon shipments were approximately 975 metric tons, or MT.]

By | 2016-03-02T07:12:51+00:00 September 12th, 2013|Categories: Chinese Stocks, DQ, SEC Original|Tags: , , , , , |0 Comments

DQ [DAQO NEW ENERGY] 6-K: Daqo New Energy Announces Unaudited Second Quarter 2013

[Daqo New Energy Announces Unaudited Second Quarter 2013 Results CHONGQING, China—September 11, 2013—Daqo New Energy Corp. (NYSE: DQ) (“Daqo New Energy” or the “Company”), a leading polysilicon manufacturer based in China, today announced its unaudited financial results for the second quarter of 2013. Second Quarter 2013 Financial and Operating Highlights • Polysilicon shipments were approximately 975 metric tons, or MT.]

By | 2016-03-02T07:15:40+00:00 September 12th, 2013|Categories: Chinese Stocks, DQ, Webplus ver|Tags: , , , , , |0 Comments

EDS [Exceed Co] 20-F/A:

[] [I, Lin Shuipan, the Chairman and Chief Executive Officer of Exceed Company Ltd. (the “Company”), certify that: 1. I have reviewed this annual report on Form 20-F/A of the Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [I, Tai Yau Ting, the Chief Financial Officer of Exceed Company Ltd. (the “Company”), certify that: 1. I have reviewed this annual report on Form 20-F/A of the Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [September 12, 2013 VIA EDGAR Mr. Larry Spirgel Assistant Director Division of Corporation Finance Re: Exceed Company Ltd. Form 20-F for the year ended December 31, 2012 Filed March 27, 2013 File No. 1-33799 Dear Mr. Spirgel: The purpose of this letter is to respond to your letter dated August 29, 2013. To assist you in reviewing our response, we]

By | 2016-03-21T01:06:30+00:00 September 12th, 2013|Categories: Chinese Stocks, EDS, Webplus ver|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] F-3: (Original Filing)

[CALCULATION OF REGISTRATION FEE Title of each class of securities to be registered (1) Amount (2) Proposed (1)(3) Proposed Amount of (4) Ordinary shares, par value $0.0001 per share Preferred shares, par value $0.0001 per share (5) Subscription rights Debt securities (6) Units Total unsold securities 68,500,000.00 4,884.05 (7) Total new securities] [12 September 2013 Matter No.: Doc Ref: RJH/3780935 Tel No.: 852 2842 9530 E-mail: Richard.Hall@conyersdill.com Chinard Bloodrporation th 48 1 Garden Road, Central Hong KongR. Dear Sirs, Re: Chinard Bloodrporation (thempany) Registration Statementmmission Securities Act Ordinary Shares Preferred Shares Equity Securities Debt Securities (the] [345 Park Avenue New York, NY 10154-1895 Direct Main Fax September 12, 2013 Chinard Bloodrporation th 48 Re: Registration Statement on Form F-3 Ladies and Gentlemen: Chinard Bloodrporation September 12, 2013 2 Page Chinard Bloodrporation September 12, 2013 3 Page Chinard Bloodrporation September 12, 2013] [. Year Ended March 31, 2013 2012 2011 2010 2009 Ratio of earnings to fixed charges 3.2 27.6 30.6 19.2 30.1 Earnings: Year Ended March 31, RMB000 2013 2012 2011 2010 2009ome beforeome tax 158,185 151,599 132,142 79,663 42,299d: Fixed charges Interest expense 70,097 3,287 2,606 2,431 (1)] [Consent of Independent Registered Public Accounting Firm The Board of Directors Chinard Bloodrporation Wensent to the use of our reportsted July 31, 2013, with respect to thensolidated balance sheets of Chinard Bloodrporation and subsidiaries of March 31, 2012 and 2013, and the relatednsolidated statements ofmprehensiveome, changes in equity, andsh flows for each of the years] [Chinard Bloodrporation 48th Floor , Bank of China Tower 1 Garden Road Central Hong KongR. Madams and Sirs , We herebynsent to the use of our name under theptions "Enforceability of Civil Liabilities ", " Legal Matters " and " Experts " in the registration statement on Form F-3 (the]

By | 2016-02-04T15:48:21+00:00 September 12th, 2013|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

SOL [ReneSola] 6-K: (Original Filing)

[RENESOLA LTD Issuance Date Date of Issuance: September __, 2013 (the “ Company ___________________________ Holder Initial Exercisability Date Placement Agent Agreement the Company’s Registration Statement on Form F-3, (the “ Registration Statement ReneSola Ltd, a company with limited liability organized under the laws of the British Virgin Islands (the “ 1. . (a) Mechanics of Exercise Exercise Day Exercise Notice] [SECURITIES PURCHASE AGREEMENT SECURITIES PURCHASE AGREEMENT Agreement Company Buyer Buyers This RECITALS Placement Agent Placement Agent Agreement Share ADS Bundled Securities A. The Company and Roth Capital Partners, LLC (the “ Shelf Registration Statement ADS Registration Statements Registration Statements Purchased ADSs ADRs Depositary Deposit Agreement ADS Securities Securities C. Each Buyer desires to subscribe and purchase, and the Company desires] [RENESOLA LTD American Depositary Shares, Each Representing Two Shares, No Par Value Per Share, together with PLACEMENT AGENT AGREEMENT September 11, 2013 Roth Capital Partners, LLC c/o Roth Capital Partners, LLC 888 San Clemente Drive Newport Beach, California 92660 Ladies and Gentlemen: Company Agreement Appendix A Securities Purchase Agreement Purchaser Purchasers Share ADS Offered Securities Offered Securities. Roth Placement Agent] []

By | 2016-03-27T09:54:50+00:00 September 12th, 2013|Categories: Chinese Stocks, SEC Original, SOL|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] F-3: CALCULATION OF REGISTRATION FEE Title of each class

[CALCULATION OF REGISTRATION FEE Title of each class of securities to be registered (1) Amount (2) Proposed (1)(3) Proposed Amount of (4) Ordinary shares, par value $0.0001 per share Preferred shares, par value $0.0001 per share (5) Subscription rights Debt securities (6) Units Total unsold securities 68,500,000.00 4,884.05 (7) Total new securities] [12 September 2013 Matter No.: Doc Ref: RJH/3780935 Tel No.: 852 2842 9530 E-mail: Richard.Hall@conyersdill.com Chinard Bloodrporation th 48 1 Garden Road, Central Hong KongR. Dear Sirs, Re: Chinard Bloodrporation (thempany) Registration Statementmmission Securities Act Ordinary Shares Preferred Shares Equity Securities Debt Securities (the] [345 Park Avenue New York, NY 10154-1895 Direct Main Fax September 12, 2013 Chinard Bloodrporation th 48 Re: Registration Statement on Form F-3 Ladies and Gentlemen: Chinard Bloodrporation September 12, 2013 2 Page Chinard Bloodrporation September 12, 2013 3 Page Chinard Bloodrporation September 12, 2013] [. Year Ended March 31, 2013 2012 2011 2010 2009 Ratio of earnings to fixed charges 3.2 27.6 30.6 19.2 30.1 Earnings: Year Ended March 31, RMB000 2013 2012 2011 2010 2009ome beforeome tax 158,185 151,599 132,142 79,663 42,299d: Fixed charges Interest expense 70,097 3,287 2,606 2,431 (1)] [Consent of Independent Registered Public Accounting Firm The Board of Directors Chinard Bloodrporation Wensent to the use of our reportsted July 31, 2013, with respect to thensolidated balance sheets of Chinard Bloodrporation and subsidiaries of March 31, 2012 and 2013, and the relatednsolidated statements ofmprehensiveome, changes in equity, andsh flows for each of the years] [Chinard Bloodrporation 48th Floor , Bank of China Tower 1 Garden Road Central Hong KongR. Madams and Sirs , We herebynsent to the use of our name under theptions "Enforceability of Civil Liabilities ", " Legal Matters " and " Experts " in the registration statement on Form F-3 (the]

By | 2016-02-04T15:48:50+00:00 September 12th, 2013|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

SOL [ReneSola] 6-K: RENESOLA LTD Issuance Date Date of Issuance: September

[RENESOLA LTD Issuance Date Date of Issuance: September __, 2013 (the “ Company ___________________________ Holder Initial Exercisability Date Placement Agent Agreement the Company’s Registration Statement on Form F-3, (the “ Registration Statement ReneSola Ltd, a company with limited liability organized under the laws of the British Virgin Islands (the “ 1. . (a) Mechanics of Exercise Exercise Day Exercise Notice] [SECURITIES PURCHASE AGREEMENT SECURITIES PURCHASE AGREEMENT Agreement Company Buyer Buyers This RECITALS Placement Agent Placement Agent Agreement Share ADS Bundled Securities A. The Company and Roth Capital Partners, LLC (the “ Shelf Registration Statement ADS Registration Statements Registration Statements Purchased ADSs ADRs Depositary Deposit Agreement ADS Securities Securities C. Each Buyer desires to subscribe and purchase, and the Company desires] [RENESOLA LTD American Depositary Shares, Each Representing Two Shares, No Par Value Per Share, together with PLACEMENT AGENT AGREEMENT September 11, 2013 Roth Capital Partners, LLC c/o Roth Capital Partners, LLC 888 San Clemente Drive Newport Beach, California 92660 Ladies and Gentlemen: Company Agreement Appendix A Securities Purchase Agreement Purchaser Purchasers Share ADS Offered Securities Offered Securities. Roth Placement Agent] []

By | 2016-03-27T09:56:01+00:00 September 12th, 2013|Categories: Chinese Stocks, SOL, Webplus ver|Tags: , , , , , |0 Comments

DQ [DAQO NEW ENERGYRP.] 6-K: Daqo New Energy Announces Unaudited Second Quarter 2013

[Daqo New Energy Announces Unaudited Second Quarter 2013 Results CHONGQING, ChinaSeptember 11, 2013Daqo New Energyrp. (NYSE: DQ) (Daqo New Energy or thempany), a leading polysilicon manufacturer based in China, today announced its unaudited financial results for the second quarter of 2013. Second Quarter 2013 Financial and Operating Highlights Polysilicon shipments were approximately 975 metric tons,]

By | 2016-02-06T15:39:17+00:00 September 12th, 2013|Categories: Chinese Stocks, DQ, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar